DOFUMARTA
LIVE

Serial Number

99127131

Owner

CivicaScript, LLC

Attorney

Joshua G. Gigger

Filing Date

Apr 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DOFUMARTA Trademark

Serial Number: 99127131

DOFUMARTA is a trademark filed by CivicaScript, LLC on April 8, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

CivicaScript, LLC (13 trademarks)

2912 Executive Parkway, Suite 320
Lehi, UT 84043

Entity Type: 16

Trademark Details

Filing Date

April 8, 2025

Registration Date

Not Registered

Published for Opposition

November 18, 2025

Goods & Services

Pharmaceutical products for the treatment of neurological diseases and disorders; pharmaceutical products for the treatment of autoimmune diseases and disorders; pharmaceutical products for the treatment of multiple sclerosis (MS); pharmaceutical products for the treatment of relapsing forms of multiple sclerosis (MS); pharmaceutical products for the treatment of clinically isolated syndrome; pharmaceutical products for the treatment of relapsing-remitting multiple sclerosis (MS) disease; pharmaceutical products for the treatment of active secondary progressive multiple sclerosis (MS) disease

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 13, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 23, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 9, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 9, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 9, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 4, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 8, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2025 NWOS
NEW APPLICATION ENTERED
Apr 8, 2025 NWAP